However, the adrenal nodule requires evaluation for possible excess hormone production or suspicion of cancer. A pheochromocytoma is a tumor that produces adrenaline. Adrenaline is commonly associated ...

Low-osmolar, contrast-enhanced CT can be safely used in patients with pheochromocytoma. “This tool will enhance physicians' abilities to diagnose and treat patients with pheochromocytoma ...

Patients with MEN-1 may develop tumors in the pancreas, which then release excess hormones. MEN type 2A can cause medullary thyroid cancer, hyperparathyroidism, and pheochromocytoma. MEN type 2B is a ...

The FDA has accepted the application for belzutifan for advanced, unresectable, or metastatic pheochromocytoma and paraganglioma.

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025.